Does supplementation with recombinant luteinizing hormone prevent ovarian hyperstimulation syndrome in down regulated patients undergoing recombinant follicle stimulating hormone multiple follicular stimulation for IVF/ET and reduces cancellation rate for high risk of hyperstimulation??

By Caserta Donatella   Lisi Franco   Marci Roberto   Ciardo Francesca   Fazi Alessandra   Lisi Roberta   Moscarini Massimo  

Gynecological Endocrinology, Vol. 27, Iss. 11, 2011-11 ,pp. : 862-866

Informa Healthcare

Access to resources Recommend Favorite

Ovarian hyper-stimulation syndrome after spontaneous conception

By Lussiana Cristina   Guani Benedetta   Restagno Gabriella   Rovei Valentina   Menato Guido   Revelli Alberto   Massobrio Marco  

Gynecological Endocrinology, Vol. 25, Iss. 7, 2009-07 ,pp. : 455-459

Informa Healthcare

Access to resources Recommend Favorite

Endocrinology: Prediction of ovarian hyperstimulation syndrome of baseline ovarian volume prior to stimulation

By Danninger B.   Brunner M.   Obruca A.   Feichtinger W.  

Human Reproduction, Vol. 11, Iss. 8, 1996-08 ,pp. : 1597-1599

Oxford University Press

Access to resources Recommend Favorite

Increased risk of ovarian hyperstimulation syndrome following controlled ovarian hyperstimulation in patients with vascular endothelial growth factor +405 cc genotype

By Hanevik Hans Ivar   Hilmarsen Hilde Tveitan   Skjelbred Camilla Furu   Tanbo Tom   Kahn Jarl A.  

Gynecological Endocrinology, Vol. 28, Iss. 11, 2012-11 ,pp. : 845-849

Informa Healthcare

Access to resources Recommend Favorite

Controlled ovarian hyperstimulation in women with polycystic ovarian syndrome with or without intrauterine insemination

By Wiser Amir   Shalom-Paz Einat   Reinblatt Shaune Leigh   Holzer Hananel   Tulandi Togas  

Gynecological Endocrinology, Vol. 28, Iss. 7, 2012-07 ,pp. : 502-504

Informa Healthcare

Access to resources Recommend Favorite